camostat has been researched along with Nephrotic Syndrome in 2 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asami, T | 1 |
Ohsawa, S | 1 |
Tomisawa, S | 1 |
Hashimoto, K | 1 |
Toyabe, S | 1 |
Sakai, K | 1 |
Makino, H | 1 |
Onbe, T | 1 |
Kumagai, I | 1 |
Murakami, K | 1 |
Ota, Z | 1 |
2 other studies available for camostat and Nephrotic Syndrome
Article | Year |
---|---|
Glomerular deposition of alpha 2-macroglobulin in a child with steroid refractory nephrotic syndrome.
Topics: alpha-Macroglobulins; Child, Preschool; Esters; Gabexate; Guanidines; Humans; Kidney Glomerulus; Mal | 1992 |
A proteinase inhibitor reduces proteinuria in nephrotic syndrome.
Topics: Esters; Gabexate; Guanidines; Humans; Nephrotic Syndrome; Protease Inhibitors; Proteinuria | 1991 |